Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

ClinicalTrials.gov ID: NCT00394771

Public ClinicalTrials.gov record NCT00394771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Double-Blinded, Randomized Study to Evaluate Bleeding Patterns in Women Using One of Three Different Doses of DR-1031 Oral Contraceptive Compared to Seasonale Oral Contraceptive Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 4-arm study to evaluate and compare bleeding patterns between three different doses of DR-1031 oral contraceptive with Seasonale oral contraceptive. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary

Study identification

NCT ID
NCT00394771
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duramed Research
Industry
Enrollment
567 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Jul 26, 2013

2006 – 2008

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801 —
Duramed Investigational Site Tucson Arizona 85741 —
Duramed Investigational Site Little Rock Arkansas 72205 —
Duramed Investigational Site San Diego California 92108 —
Duramed Investigational Site San Francisco California 94102 —
Duramed Investigational Site Santa Ana California 92705 —
Duramed Investigational Site Vista California 92083 —
Duramed Investigational Site Pueblo Colorado 81001 —
Duramed Investigational Site Stratford Connecticut 06615 —
Duramed Investigational Site DeLand Florida 32720 —
Duramed Investigational Site Jacksonville Florida 32207 —
Duramed Investigational Site Melbourne Florida 32935 —
Duramed Investigational Site Miami Florida 33186 —
Duramed Investigational Site Tampa Florida 33607 —
Duramed Investigational Site West Palm Beach Florida 33401 —
Duramed Investigational Site West Palm Beach Florida 33407 —
Duramed Investigational Site Alpharetta Georgia 30005 —
Duramed Investigational Site Douglasville Georgia 30134 —
Duramed Investigational Site Savannah Georgia 31406 —
Duramed Investigational Site Boise Idaho 83712 —
Duramed Investigational Site Meridian Idaho 83642 —
Duramed Investigational Site Fort Wayne Indiana 46825 —
Duramed Investigational Site Wichita Kansas 67205 —
Duramed Investigational Site Baton Rouge Louisiana 70808 —
Duramed Investigational Site Metairie Louisiana 70006 —
Duramed Investigational Site Shreveport Louisiana 71106 —
Duramed Investigational Site Riverdale Maryland 20737 —
Duramed Investigational Site Kansas City Missouri 64114 —
Duramed Investigational Site Las Vegas Nevada 89109 —
Duramed Investigational Site Las Vegas Nevada 89128 —
Duramed Investigational Site North Las Vegas Nevada 89030 —
Duramed Investigational Site Lebanon New Hampshire 03756 —
Duramed Investigational Site Cary North Carolina 27511 —
Duramed Investigational Site New Bern North Carolina 28562 —
Duramed Investigational Site Winston-Salem North Carolina 27103 —
Duramed Investigational Site Cleveland Ohio 44122 —
Duramed Investigational Site Mayfield Heights Ohio 44124 —
Duramed Investigational Site Eugene Oregon 97401 —
Duramed Investigational Site Medford Oregon 97504 —
Duramed Investigational Site Pittsburgh Pennsylvania 15206 —
Duramed Investigational Site Charleston South Carolina 29425 —
Duramed Investigational Site Columbia South Carolina 29201 —
Duramed Investigational Site Hilton Head Island South Carolina 29926 —
Duramed Investigational Site Jackson Tennessee 38305 —
Duramed Investigational Site Austin Texas 78737 —
Duramed Investigational Site Dallas Texas 75390 —
Duramed Investigational Site Houston Texas 77024 —
Duramed Investigational Site San Antonio Texas 78229 —
Duramed Investigational Site Salt Lake City Utah 84102 —
Duramed Investigational Site Williston Vermont 05495 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00394771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00394771 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →